SARS-CoV-2 detection in nasopharyngeal throat swabs by metagenomics

Metagenomics could detect SARS-CoV-2 in all eight nasopharyngeal/throat swabs with high/low viral loads, and rhinovirus in a co-infected patient. The sequenced viruses belonged to lineage B1. Because metagenomics could detect novel pathogen and co-infection, and generate sequence data for epidemiological investigation, it is an attractive approach for infectious-disease diagnosis.

Information about duration of stay and clinical and laboratory findings are presented in 7 4

5
Metagenomics generated a total of 2-4 million reads per sample in 7/8 included NTS. In the 7 6 remaining sample, ¼ million reads were obtained (Table 2). SARS-CoV-2 were detected in 7 7 sequence data obtained from all eight RT-PCR positive NTS samples by both IDseq and 7 8 DISCVR, but not in the NTS sample. One patient presenting with respiratory infection was 7 9 co-infected with rhinovirus, which was also detected by metagenomics.  Table 1).

6
The emergence of SARS-CoV-2 emphasizes the continuous unprecedented threat posed by 8 7 emerging infectious diseases, especially those caused by novel viruses. The diagnosis of 8 8 respiratory diseases is highly challenging because the responsible pathogens are diverse. In 8 9 addition, the emergence of novel pathogens further challenges routine diagnosis. Indeed, 9 0 SARS-CoV-2 initially went undetected by PCR panels targeted at common respiratory 9 1 viruses [2]. New diagnostic approach is therefore urgently needed to address the ongoing 9 2 challenge posed by emerging infections.

3
Here, we demonstrated that when coupled with publically available bioinformatics tools, 9 4 metagenomics could detect SARS-CoV-2 in RT-PCR positive NTS samples with a wide 9 5 range of viral loads. The data suggests that metagenomics is a sensitive assay for SARS-9 6 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 26, 2020. .
CoV-2 diagnosis and detection of co-infection as illustrated by the detection of rhinovirus, 9 7 in line with a recent report [4], important for clinical management. In addition to providing 9 8 diagnostic information, the obtained sequences also allows for genetic characterization, and 9 9 detection of genetic variations in the genomes of the pathogen under investigation. Indeed, 1 0 0 using the obtained sequences, we successfully identified that all the Vietnamese viruses 1 0 1 included for analysis belonged to lineage B1, which has been found worldwide [11]. In line    The application of metagenomics for SARS-CoV-2 and respiratory diagnosis would be 1 1 1 highly relevant in the near future. This is because SARS-CoV-2 has spread globally, and metagenomics is a preferable method because of its ability to detect both known and 1 1 9 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 26, 2020. . unknown pathogens presenting in the tested specimens without the need of pathogen 1 2 0 specific PCR primers [1, 13].

2 1
Our study has some limitations. Only a small number of patients were included for analysis, 1 2 2 owing to the nature of a pilot in itself. However during the study period, there were only 14 1 2 3 SARS-CoV-2 confirmed cases reported in our setting, Ho Chi Minh City, Vietnam. As a 1 2 4 consequence, we were not able to properly assess the sensitivity and specificity of 1 2 5 metagenomics for the diagnosis of COVID-19.

2 6
In summary, we show that metagenomics is a sensitive assay for sequence-independent 1 2 7 detection of SARS-CoV-2 NTS samples. The ability of metagenomics to detect co-infection 1 2 8 and novel pathogens, and generate sequence data for molecular epidemiological 1 2 9 investigation makes it an attractive approach for infectious disease diagnosis.
CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 26, 2020. .

3 3
We are indebt to Ms Nguyen Thanh Ngoc, Ms Le Kim Thanh, and the OUCRU 1 3 4 IT/CTU/Laboratory Management departments for their support.    Italy. JAMA, 2020.

1
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 26, 2020. .
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted May 26, 2020. .  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 26, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 26, 2020. . https://doi.org/10.1101/2020